Biotricity Inc.

BTCY Healthcare Medical Devices

Biotricity Inc.’s revenue for fiscal 2026 (year ended March 2026) was $16.0 million, up 16.0% from fiscal 2025. In the quarter to June 2026, revenue grew 10.4%, EPS fell 66.7%, free cash flow grew 235.8% and total debt rose 3.48%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

0.05 0.00 0.00%
Market cap
$10.9M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
5/9
Altman Z
−33.34
Beneish M
−3.24
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
9.75% 9.38% 14.19% 15.07%

+8 more TTM periods

Piotroski F-Score
6 5 4 5
ROA
(57.12%) (51.76%) (80.47%) (83.81%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
10.85% 10.00% 24.97% 26.93%
Average Days of Receivables
53.36 66.91 37.29 50.80
Free Cash Flow per Share
0.01 (0.03) (0.04) (0.02)
Free Cash Flow
0.16 (0.72) (1.10) (0.45)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 28 Sep 2026